ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för heparin proteoglycan. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

18 träffar

Bibliografisk träff 2021-11-13

AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan).

Winzely M, Jouppila A, Ramer G, Lux L, Lendl B, Barreiro K, Lassila R, Friedbacher G.

Anal Bioanal Chem · research-article; journal article · DOI 10.1007/s00216-021-03765-y

Bibliografisk träff 2018-07-25

Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation.

Chen J, Verni CC, Jouppila A, Lassila R, Diamond SL.

Thromb Res · research-article; journal article · DOI 10.1016/j.thromres.2018.07.026

Bibliografisk träff 2014-11-13

Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.

Lassila R, Jouppila A.

Semin Thromb Hemost · review; journal article · DOI 10.1055/s-0034-1395157

Bibliografisk träff 2002-02-01

Topically administered macromolecular heparin proteoglycans inhibit thrombus growth in microvascular anastomoses.

Olsson E, Asko-Seljavaara S, Lassila R.

Thromb Haemost · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1055/s-0037-1612980

Bibliografisk träff 2000-11-01

Coimmobilized native macromolecular heparin proteoglycans strongly inhibit platelet-collagen interactions in flowing blood.

Kauhanen P, Kovanen PT, Lassila R.

Arterioscler Thromb Vasc Biol · research support, non-u.s. gov't; journal article · DOI 10.1161/01.atv.20.11.e113

Bibliografisk träff 1999-09-01

Mechanism by which heparin proteoglycan modulates mast cell chymase activity.

Pejler G, Sadler JE.

Biochemistry · research support, non-u.s. gov't; journal article · DOI 10.1021/bi991046b

Bibliografisk träff 1999-05-01

Mast cell granule heparin proteoglycan induces lacunae in confluent endothelial cell monolayers.

Lagunoff D, Rickard A.

Am J Pathol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article · DOI 10.1016/s0002-9440(10)65412-0

Bibliografisk träff 1999-01-01

Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture.

Wang Y, Kovanen PT.

Circ Res · journal article · DOI 10.1161/01.res.84.1.74

Bibliografisk träff 1997-12-01

Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions.

Lassila R, Lindstedt K, Kovanen PT.

Arterioscler Thromb Vasc Biol · research support, non-u.s. gov't; journal article · DOI 10.1161/01.atv.17.12.3578

Bibliografisk träff 1996-04-01

Mast cell chymase in complex with heparin proteoglycan is regulated by protamine.

Pejler G.

FEBS Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/0014-5793(96)00239-6

Bibliografisk träff 1995-10-01

Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.

Lidholt K, Eriksson I, Kjellén L.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj3110233

Bibliografisk träff 1995-10-01

Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.

Pejler G, Berg L.

Eur J Biochem · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1432-1033.1995.192_1.x

Bibliografisk träff 1994-04-01

Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

Pejler G, Söderström K, Karlström A.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj2990507

Bibliografisk träff 1990-11-01

Oxidative degradation of rat mast-cell heparin proteoglycan.

Metcalfe DD, Thompson HL, Klebanoff SJ, Henderson WR.

Biochem J · research support, u.s. gov't, p.h.s.; research-article; journal article · DOI 10.1042/bj2720051

Bibliografisk träff 1990-07-01

Synthesis of chondroitin sulfate D and heparin proteoglycans in murine lymph node-derived mast cells. The dependence on fibroblasts.

Davidson S, Gilead L, Amira M, Ginsburg H, Razin E.

J Biol Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/s0021-9258(19)38349-8

Bibliografisk träff 1989-09-01

Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.

Horner AA.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj2620953

Bibliografisk träff 1988-04-01

Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells.

Stevens RL, Fox CC, Lichtenstein LM, Austen KF.

Proc Natl Acad Sci U S A · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article · DOI 10.1073/pnas.85.7.2284

Bibliografisk träff 1986-12-01

Location of antithrombin-binding regions in rat skin heparin proteoglycans.

Jacobsson KG, Lindahl U, Horner AA.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj2400625